Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OZURDEX With or Without Laser for Persistent Diabetic Macular Edema
ChiCTR2100043460Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Aug 2019
- Modality
- Small Molecules, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of ozurdex in diabetic macular edema (DME) (2 arms), sponsored by Tongji Hospital. Primary endpoint: Best corrected visual acuity. Started Aug 2019; status: recruiting.
02
Drugs
ozurdex
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on ChiCTR2100043460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043460.